Economic Evaluation of a Steroid‐Eluting Sinus Implant following Endoscopic Sinus Surgery for Chronic Rhinosinusitis
Authors:
- 5 May 2014
- journal article
- research article
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 151 (2) , 359-366
Abstract
Objective: This study aimed to evaluate the cost‐effectiveness of a mometasone steroid‐eluting sinus implant compared to a nonsteroid‐eluting sinus implant following endoscopic sinus surgery (ESS) for chronic rhinosinusitis.Study Design: Economic evaluation using a decision tree model.Setting: Academic and nonacademic otolaryngology practices.Subjects: Patients with refractory chronic rhinosinusitis undergoing ESS.Methods: The economic perspective was the health care third party payer. Effectiveness and probability data were obtained from a single meta‐analysis of 2 randomized, double‐blind, controlled trials. Costs were obtained from the Centers for Medicare & Medicaid Services database and wholesale pharmaceutical pricing. Multiple sensitivity analyses were performed including a probabilistic sensitivity analysis. Comparative treatment groups were (1) placement of the mometasone steroid‐eluting sinus implant following ESS and (2) placement of a nonsteroid‐eluting implant following ESS. The primary outcome was cost per postoperative intervention avoided within 60 days after ESS.Results: The mean cost for the steroid‐eluting and nonsteroid‐eluting sinus implant strategies were $1,572.91 and $365.18, respectively. The steroid‐eluting strategy incremental cost‐effectiveness ratio was $5,489.68. The sensitivity analysis demonstrated a 74.3%, 87.2%, and 90.5% certainty that the steroid‐eluting implant strategy is cost‐effective at willingness‐to‐pay thresholds of $10,000, $25,000, and $50,000, respectively.Conclusion: Results from this economic evaluation suggest that placement of a mometasone steroid‐eluting sinus implant into the ethmoid cavity following ESS for refractory chronic rhinosinusitis is a cost‐effective intervention for preventing a postoperative intervention within 60 days after surgery.Keywords
Funding Information
- National Institutes of Health
This publication has 16 references indexed in Scilit:
- What is new and promising with drug-eluting stents in sinus surgery?Current Opinion in Otolaryngology & Head and Neck Surgery, 2014
- Health economic evaluation: Important principles and methodologyThe Laryngoscope, 2013
- Effect of steroid‐releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta‐analysisInternational Forum of Allergy & Rhinology, 2012
- Advance IIOtolaryngology–Head and Neck Surgery, 2012
- Early postoperative care following endoscopic sinus surgery: an evidence‐based review with recommendationsInternational Forum of Allergy & Rhinology, 2011
- ADVANCE: A multisite trial of bioabsorbable steroid‐eluting sinus implantsThe Laryngoscope, 2011
- Safety and efficacy of a novel bioabsorbable, steroid‐eluting sinus stentInternational Forum of Allergy & Rhinology, 2011
- Are routine dissolvable nasal dressings necessary following endoscopic sinus surgery?The Laryngoscope, 2010
- Ambulatory sinus and nasal surgery in the United States: Demographics and perioperative outcomesThe Laryngoscope, 2010
- Stents and Drug-Eluting StentsOtolaryngologic Clinics of North America, 2009